Recent advances in hyperthermia therapy‐based synergistic immunotherapy
The past decades have witnessed hyperthermia therapy (HTT) as an emerging strategy
against malignant tumors. Nanomaterial‐based photothermal therapy (PTT) and magnetic …
against malignant tumors. Nanomaterial‐based photothermal therapy (PTT) and magnetic …
Applications of inorganic nanomaterials in photothermal therapy based on combinational cancer treatment
J Wang, X Wu, P Shen, J Wang, Y Shen… - International Journal …, 2020 - Taylor & Francis
Background Cancer is one of the major causes of death and is difficult to cure using existing
clinical therapies. Clinical cancer treatments [such as surgery, chemotherapy (CHT) …
clinical therapies. Clinical cancer treatments [such as surgery, chemotherapy (CHT) …
Exosome-based tumor antigens–adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA
M Morishita, Y Takahashi, A Matsumoto, M Nishikawa… - Biomaterials, 2016 - Elsevier
For cancer immunotherapy via tumor antigen vaccination in combination with an adjuvant,
major challenges include the identification of a particular tumor antigen and efficient delivery …
major challenges include the identification of a particular tumor antigen and efficient delivery …
Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles
L Guo, DD Yan, D Yang, Y Li, X Wang, O Zalewski… - ACS …, 2014 - ACS Publications
Near-infrared light-responsive inorganic nanoparticles have been shown to enhance the
efficacy of cancer photothermal ablation therapy. However, current nanoparticle-mediated …
efficacy of cancer photothermal ablation therapy. However, current nanoparticle-mediated …
Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens
DS Watson, AN Endsley, L Huang - Vaccine, 2012 - Elsevier
Liposomes (phospholipid bilayer vesicles) are versatile and robust delivery systems for
induction of antibody and T lymphocyte responses to associated subunit antigens. In the last …
induction of antibody and T lymphocyte responses to associated subunit antigens. In the last …
[HTML][HTML] RNA nanotechnology-mediated cancer immunotherapy
RNA molecules (eg, siRNA, microRNA, and mRNA) have shown tremendous potential for
immunomodulation and cancer immunotherapy. They can activate both innate and adaptive …
immunomodulation and cancer immunotherapy. They can activate both innate and adaptive …
Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and co-delivery platform for enhanced cancer immunotherapy
Silica based nanoparticles have emerged as a promising vaccine delivery system for cancer
immunotherapy, but their bio-degradability, adjuvanticity and the resultant antitumor activity …
immunotherapy, but their bio-degradability, adjuvanticity and the resultant antitumor activity …
Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system
N Hanagata - International journal of nanomedicine, 2012 - Taylor & Francis
Unmethylated cytosine-phosphate-guanosine (CpG) oligodeoxynucleotides (ODNs) are
recognized by Toll-like receptor 9 (TLR9) found in antigen-presenting cells and B cells and …
recognized by Toll-like receptor 9 (TLR9) found in antigen-presenting cells and B cells and …
CpG oligodeoxynucleotides for anticancer monotherapy from preclinical stages to clinical trials
CpG oligodeoxynucleotides (CpG ODNs), the artificial versions of unmethylated CpG motifs
that were originally discovered in bacterial DNA, are demonstrated not only as potent …
that were originally discovered in bacterial DNA, are demonstrated not only as potent …
Polyvalent immunostimulatory nanoagents with self‐assembled CpG oligonucleotide‐conjugated gold nanoparticles
Transportvehikel: Gold‐Nanopartikel (AuNPs) werden als Träger für die nichtinvasive
Einschleusung von synthetischen Cytosinphosphatguanosin (CpG) …
Einschleusung von synthetischen Cytosinphosphatguanosin (CpG) …